Weeks, Elle M. http://orcid.org/0000-0002-4317-4444
Ulirsch, Jacob C. http://orcid.org/0000-0002-7947-0827
Cheng, Nathan Y.
Trippe, Brian L.
Fine, Rebecca S.
Miao, Jenkai
Patwardhan, Tejal A.
Kanai, Masahiro http://orcid.org/0000-0001-5165-4408
Nasser, Joseph
Fulco, Charles P.
Tashman, Katherine C.
Aguet, Francois http://orcid.org/0000-0001-9414-300X
Li, Taibo http://orcid.org/0000-0002-6624-9293
Ordovas-Montanes, Jose
Smillie, Christopher S.
Biton, Moshe
Shalek, Alex K.
Ananthakrishnan, Ashwin N.
Xavier, Ramnik J.
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Gupta, Rajat M.
Lage, Kasper
Ardlie, Kristin G.
Hirschhorn, Joel N.
Lander, Eric S.
Engreitz, Jesse M. http://orcid.org/0000-0002-5754-1719
Finucane, Hilary K. http://orcid.org/0000-0003-3864-9828
Article History
Received: 14 August 2020
Accepted: 9 June 2023
First Online: 13 July 2023
Competing interests
: J.C.U. reports compensation from consulting services with Goldfinch Bio and is an employee of Illumina. R.S.F. is an employee of Vertex Pharmaceuticals Incorporated. C.P.F. is an employee of Bristol Myers Squibb. J.O.-M. reports compensation for consulting services with Cellarity. A.R. is a cofounder and equity holder of Celsius Therapeutics and an equity holder in Immunitas, and was an SAB member of Thermo Fisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov until 31 July 2020. From 1 August 2020, A.R. is an employee of Genentech. J.N.H. served on the Scientific Advisory Board of and consults for Camp4 Therapeutics. E.S.L. serves on the Board of Directors for Codiak BioSciences and Neon Therapeutics, and serves on the Scientific Advisory Board of F-Prime Capital Partners and Third Rock Ventures; he is also affiliated with several nonprofit organizations including serving on the Board of Directors of the Innocence Project, Count Me In and Biden Cancer Initiative, and the Board of Trustees for the Parker Institute for Cancer Immunotherapy. He has served and continues to serve on various federal advisory committees. The remaining authors declare no competing interests.